Severe Thrombocytopenia as a Presenting Manifestation of Kawasaki Disease

Thrombocytopenia in Kawasaki Disease: A Risk Factor for the Development of Coronary Artery Aneurysms

“……”

“……”

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association

“…Perhaps for this reason, adverse effects appear to vary considerably among products. [153][154][155] The results of clinical studies comparing the efficacy of immune globulin products have conflicted, 156,157 with most studies failing to find a significant difference between brands. Within the US health care system, the use of high-dose IVIG is cost-effective.…”

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease

“…Perhaps for this reason, adverse effects appear to vary considerably among products. [153][154][155] The results of clinical studies comparing the efficacy of immune globulin products have conflicted, 156,157 with most studies failing to find a significant difference between brands. Within the US healthcare system, the use of high-dose IVIG is cost-effective.…”